إعلان
إعلان

ACIU

ACIU logo

AC Immune SA

3.41
USD
برعاية
-0.03
-0.81%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

3.42

+0.01
+0.23%

تقارير أرباح ACIU

النسبة الإيجابية المفاجئة

ACIU تفوق 21 من 36 آخر التقديرات.

58%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.25M
/
-$0.16
التغير الضمني من Q3 25 (Revenue/ EPS)
+33.23%
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
+10.03%
/
--

AC Immune SA earnings per share and revenue

On ٠٤ نوفمبر ٢٠٢٥, ACIU reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.19 USD, resulting in a 17.95% surprise. Revenue reached 939.00 ألف, compared to an expected 829.55 ألف, with a 13.19% difference. The market reacted with a +3.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.16 USD, with revenue projected to reach 1.25 مليون USD, implying an زيادة of 0.00% EPS, and زيادة of 33.23% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, AC Immune SA reported EPS of -$0.16, beating estimates by 17.95%, and revenue of $939.00K, 13.19% above expectations.
The stock price moved up 3.77%, changed from $3.18 before the earnings release to $3.30 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 5 المحللين, AC Immune SA is expected to report EPS of -$0.16 and revenue of $1.25M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان